JUL 22, 2019 2:39 PM PDT

New Freezing Technique for Breast Cancer Patients in Low Income Countries

WRITTEN BY: Julia Travers

Treatment for breast cancer can be too expensive and hard to access for many women in lower-income countries. These women are disproportionately affected by breast cancer and experience a higher related mortality rate. In the United States, more than 90 percent of women survive breast cancer. But in countries like The Gambia, Saudi Arabia or Uganda, survival rates are much lower, ranging from about 12 to 64 percent.

A student-led research team of the Biomedical Engineering Design Program at Johns Hopkins University is creating a novel approach to bringing successful treatment to more breast cancer patients around the world. Many of these women cannot afford or reach procedures like chemotherapy, radiation and surgery. Cryoablation, or killing cancerous tissue by freezing it, can be preferable because it does not require an operating room or anesthesia and so can be performed in community clinics.

This technique typically uses argon gas, which can cost as much as $10,000 per treatment and can be hard to come by in many parts of the world. The Johns Hopkins team used carbon dioxide instead, which is much cheaper and easier to find. According to EurekAlert, they tested this procedure in three experiments that mimicked the temperatures and conditions of human breasts, finding it could successfully kill tumor tissue. The three test materials or environments were ultrasound gel, rats with mammary tumors and the normal liver of a pig. The device met standard freezing temperatures for tissue death for similar U.S. devices and killed at least 85 percent of the tumor tissue.

"Innovation in cancer care doesn't always mean you have to create an entirely new treatment, sometimes it means radically innovating on proven therapies such that they're redesigned to be accessible to the majority of the world's population," Bailey Surtees, the study's first author and a Johns Hopkins University biomedical engineering graduate, said. The researchers now plan to continue testing the device for use with people and also hope to broaden its application to pets. Their findings were published in July 2019 in PLOS One.

 

An animation of the procedure is below:

 

 

Source: EurekAlert

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUL 17, 2020
Cancer
Tackling the Problem of Toxicity in Breast Cancer Therapy
JUL 17, 2020
Tackling the Problem of Toxicity in Breast Cancer Therapy
Chemotherapy has been one of the primary methods of cancer treatment for decades. Usually, a doctor applies a chemothera ...
JUL 18, 2020
Cancer
Clinical trials go forth for osteosarcoma in dogs and glioblastoma multiforme in humans using the same precision medicine
JUL 18, 2020
Clinical trials go forth for osteosarcoma in dogs and glioblastoma multiforme in humans using the same precision medicine
A development in precision medicine in cancer treatment for dogs has led to a similar advancement in cancer treatment fo ...
JUL 30, 2020
Cancer
Researchers say DBT doesn't serve women with "extremely dense" breasts
JUL 30, 2020
Researchers say DBT doesn't serve women with "extremely dense" breasts
When you undergo screening for breast cancer, you usually have to have a mammogram, an x-ray that looks for abnormal mas ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
SEP 14, 2020
Cancer
We are too uneducated on the risks of colon cancer
SEP 14, 2020
We are too uneducated on the risks of colon cancer
A study conducted by researchers from Florida Atlantic University's Schmidt College of Medicine suggests that too ma ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
Loading Comments...